Introduction {#S0001}
============

*Helicobacter pylori* (*H. pylori*) is spread worldwide, with a high prevalence rate in the developing countries.[@CIT0001] It causes gastritis; gastric and duodenal ulcers; gastric cancer; and mucosa- associated lymphoid tissue (MALT) lymphoma.[@CIT0002]--[@CIT0005] It is classified by the World Health Organization as a group 1 carcinogen for gastric adenocarcinoma in adults.[@CIT0006] Unless treated during childhood, *H. pylori* infection will persist and continue till adulthood causing the above mentioned sequel.[@CIT0002],[@CIT0003] Its prevalence varies among developed and developing countries, ranging (34.7--82%),[@CIT0001],[@CIT0007] with a unique age-specific prevalence pattern in the developing countries manifesting with higher prevalence rates in adults compared to children.[@CIT0001]

Several diagnostic tests are used to detect *H. pylori* infection,[@CIT0008] with the initial diagnosis in children involving endoscopy and histological evaluation.[@CIT0005],[@CIT0009] Endoscopic findings in *H. pylori* infection in children are variable, with nodular gastric mucosa being a characteristic finding in the high prevalence countries.[@CIT0010],[@CIT0011] Describing histological specimens containing *H. pylori* is variable,[@CIT0008] with the updated Sydney classification widely used in adults for this purpose.[@CIT0012],[@CIT0013] The classification grades the stomach biopsy in regard to 4 domains: chronicity (based on presence of lymphocytes); activity (based on presence of neutrophils), glandular atrophy; and metaplasia.[@CIT0012],[@CIT0014]

*H. pylori* infection in children has been linked to several extra gastric effects; including iron deficiency anemia (IDA), idiopathic thrombocytopenic purpura (ITP), subnormal growth, short stature, diarrhea, diabetes mellitus, and recently atopy.[@CIT0015]--[@CIT0020] The relation of *H. pylori* to IDA has been widely studied, but the findings are still conflicting.[@CIT0005],[@CIT0009],[@CIT0018],[@CIT0019]

Limited data exist about histology-based prevalence (HBP) of *H. pylori* in Arab children. Studies from Kuwait, Saudi Arabia, Egypt, and Oman showed the prevalence of *H. pylori* to be 31%, 62%, 65% and 25 %, respectively.[@CIT0021]--[@CIT0024] In Jordan, studies estimated the HBP of *H. pylori* in adults to be 68%--82%,[@CIT0007],[@CIT0025],[@CIT0026] and the presence of *H. pylori* infection was documented in 50--79% of gastric cancer biopsies in adult Jordanians.[@CIT0027],[@CIT0028] Serology - based studies in asthmatic and healthy Jordanian children estimated *H. pylori* prevalence to range from 18.1% to 55.5%, respectively.[@CIT0020],[@CIT0029] One study in dyspeptic children from northern Jordan estimated the HBP to be 82%.[@CIT0030]

This study aimed to measure, the HBP of *H. pylori* in symptomatic Jordanian children, and to quantify the impact of *H. pylori* infection on the gastric inflammation and anemia. Our secondary goal was to study possible predictors for *Helicobacter pylori* presence in this cohort.

Methods {#S0002}
=======

This was a retrospective chart review study. Children who underwent esophageo-gastro-duodenoscopy (EGD) at the Jordan University Hospital (JUH) between January 2008 and January 2016 were enrolled. Ethical approval was obtained from the institutional review board (IRB) committee at the school of medicine, University of Jordan, Amman, Jordan, and from the IRB committee at JUH.

JUH is a 600-bed tertiary hospital located in Amman city, the capital of Jordan. JUH has about 500,000 yearly patient visits to the outpatient department and about 100,000 yearly visits to the emergency room. Patients come to JUH from all regions of the country but mainly from Amman and central Jordan, which represent the highest population density in the country.

Children aged 1 to 18 years who had EGD done at JUH during the study period were included. Both clinic and hospitalized patients were included in the study. Children who had gastric biopsy obtained at the time of endoscopy were included. Any child who had biopsies and endoscopy done more than once was counted as one unique patient. Children were excluded if their endoscopy or biopsy report were missing from the medical file, or if the gastric biopsy slides were missing. Children known to have the following gastrointestinal diseases were excluded: inflammatory bowel disease IBD; celiac disease; or eosinophilic esophagitis EoE. Children with other nationalities, who had EGD done at JUH during the study period, were excluded from the study.

Data collected about study subjects included age at the time of EGD; gender; residence location; usage of proton pump inhibitors (PPI); indication(s) for endoscopy; endoscopy findings as reported in the endoscopy report; and complete blood count done within 3 months from endoscopy.

Over the study period, EGDs were performed by two pediatric gastroenterologists (MR and FKA) under either general anesthesia or sedation. Biopsies were obtained from the gastric antrum and/or the gastric body, with at least two biopsies were taken from each site. Gastric biopsies were submitted for histology, placed in slides, stained with hematoxylin and eosin stain (Abbey Color, Philadelphia, PA, USA), and were assessed, at the time of endoscopy, by a pathologist. The pathologist organized a report about the findings, and it was kept in the patient's medical file. The same biopsy slides were examined again at the time of this study by an expert pathologist (TA), who was blinded to the initial pathology report. He looked for the presence of gastritis and *H. pylori* according to the updated Sydney classification. Results of his new report and old report were compared.

To ensure data privacy, each study subject was assigned a unique study number. This number was linked to the subject's clinical data. The list containing study subject names with their assigned numbers was kept in a password- protected MS-word file, which was kept on a password - protected computer used only by the primary investigator (FKA). Clinical data was initially recorded on an intake sheet for each de-identified study subject, and then was entered on excel spread sheet. This sheet was password - protected and kept at FKA computer.

Descriptive statistics were used to describe the demographic data. For categorical variables, frequencies and percentages were reported. Comparisons of categorical variables were carried out using Pearson's chi-square test. Possible predictors of *H. pylori* presence were assessed using logistic regression analysis for each independent (predicted) variable. An a priori two-tailed level of significance was set at 0.05 levels. Statistical analyses were conducted using statistical Package for the Social Sciences version 20 (SPSS Inc. Chicago, IL, USA).

Results {#S0003}
=======

A total of 228 children had EGD with gastric biopsies taken during the study period. 58 were excluded due to missing biopsy slides; 30 were excluded due to missing clinical data; 18 were excluded due to missing endoscopy or biopsy report; and 12 children were excluded due to prior diagnosis of IBD, celiac disease, or EoE. Three children had EGD done twice, so they were counted as three unique patients instead of six. Another 9 children were excluded because they were non-Jordanian nationals. The total study cohort was 98. [Table 1](#T0001){ref-type="table"} summarizes the study population characteristics.Table 1Demographic Data of the Study PopulationCharacterNumber (%)Total number98Gender Male45(46) Female53(54)Age range1 year -- 18 yearsMean ± SD12.1 years ± 4.6 yearsAge group distribution \<5 years9 (9)5-10 Years27 (28) \>10 years62 (63)Residence Northern Jordan ^a^5 (5) Central Jordan ^b^91 (93) Southern Jordan ^c^2 (2)Medications: Proton pump inhibitors34 (35)[^1]

The HBP of *H. pylori* in this study cohort of 98 children was 54%. [Table 2](#T0002){ref-type="table"} demonstrates the details of demographic findings. The majority of *H. pylori*-positive children were boys; older than 10 years of age; and lived in central Jordan. There was a progressive increment of *H. pylori* prevalence with age in this study cohort ([Figure 1](#F0001){ref-type="fig"}). The majority of *H. pylori* negative children were taking PPI at the time of endoscopy, 32 children out of 45 (%71). No significant difference was found in the prevalence of anemia in regard to the presence or absence of *H. pylori* infection. This is illustrated in [Table 2](#T0002){ref-type="table"}.Table 2Demographic Date of *H. pylori* in Jordanian ChildrenCharacter*H. pylori* Positive N (%)*H. pylori* Negative N (%)P valueTotal number53(54)45 (46)0.482Gender Male29(55)16(36)0.077 Female24(45)29(64)0.686Age Mean (range) in years12.2 (1--18)12 (2--18)1.000 ± SD4.84.6 \< 5 years3(6)6(13)0.480 5--10 years16(30)11(24)0.317 \>10 years34(64)28(63)0.446Northern Jordan ^a^410.180Central Jordan ^b^49420.463Southern Jordan ^c^02--Medications: Proton pump inhibitors2320.000Anemia: HGB less than 11 mg/ dl5(9)7(16)0.564[^2] Figure 1Age distribution of *H. pylori* -positive children.

Abdominal pain was the most common indication for endoscopy, but it was not statistically different between the group which had *H. pylori* and the group that did not (p value \> 0.05). None of the other indications for endoscopy was significant either. [Table 3](#T0003){ref-type="table"} lists all indications for endoscopy. Several patients had more than one indication for endoscopy.Table 3Frequency of Endoscopy Indications in the Study PopulationIndication ^a^Frequency of Endoscopy IndicationP value^c^Study Population N^b^ (%)*H. pylori* Positive N^b^ (%)*H. pylori* Negative N^b^ (%)Abdominal pain80 (53)42 (53)38 (54)0.655Vomiting26 (18)15 (18)11 (17)0.433Constipation10 (7)3 (4)7 (10)0.206Abdominal distension7 (5)5 (6)2 (4)0.257Weight loss10(7)5 (7)5 (7)1.000Diarrhea4 (3)3 (4)1 (1)0.317Positive celiac serology5 (3)3 (4)2 (2)0.655OthersHematemesis2 (1)1 (1)1 (1)1.000Melena/ positive heme occult2(2)1 (1)1 (2)1.000Recurrent oral ulcers2(1)1 (1)1 (1)1.000Caustic ingestion2(1)1 (1)1 (1)1.000Number of endoscopy indications150 (100)80 (100)70 (100)0.414[^3]

The majority of the study cohort had normal endoscopy findings ([Table 4](#T0004){ref-type="table"}). Nodularity of the gastric mucosa was seen in 43% of the *H. pylori*-positive group and only in 11% of the *H. pylori* negative group. This was statistically significant, with p-value \<0.05. Stomach ulcers were seen in only 3 (3%) children, but only one of them had *H. pylori*. Ulcers in the other 2 children were due to non-steroidal anti-inflammatory drugs (NSAID) ingestion.Table 4Endoscopic Findings in the Study PopulationEndoscopic Finding*H. pylori* Positive\
N (%)*H. pylori* Negative N (%)P valueNormal endoscopy22(42)33(74)0.174Nodularity23(43)5(11)0.001Erosions7(13)5(11)0.564Ulcers1(2)2(4)0.564

Based on the updated Sydney classification of gastritis, two thirds of children who had *H. pylori* had moderate to severe chronic gastritis, whereas two thirds of those who did not have *H. pylori* had absent to mild chronic gastritis ([Table 5](#T0005){ref-type="table"}). Moderate chronic gastritis was statistically higher in the *H. pylori* positive group (p value \<0.05). The presence of *H. pylori* was significantly associated with active gastritis (p value \<0.05). Glandular atrophy and intestinal metaplasia were rarely seen in this children cohort. There was a 100% concordance between the initial pathology report at the time of endoscopy and the one re-produced during this study.Table 5Histology Descriptions Based on Updated Sydney Classification*H. pylori* Positive N (%)*H. pylori* Negative N (%)P valueChronic inflammationAbsent0(0)7(16)--Mild22(41)24(53)0.768Moderate21(40)8(18)0.016Sever10(19)6(13)0.317Polymorph nuclear cell activityAbsent25(47)36(80)0.159Present28(53)9(20)0.002Glandular atrophyPresent2(4)0 (0)--Absent51(96)45(100)0.540MetaplasiaPresent2(4)0(0)--Absent51(96)45(100)0.540

Using logistic regression to evaluate for possible predictors for *H. pylori* ([Table 6](#T0006){ref-type="table"} ), the presence of nodularity by endoscopy, and the presence of active gastritis by histology were statistically significant variables (p value \< 0.05).Table 6Variables Predictors for *H. pylori* InfectionIndependent VariableRR SquareFSig.Beta UnstandardizedtSig.Demographic dataAge.046^a^.002.207.650^a^.005.455.650Gender.192^a^.0373.659.059^a^−.192-−1.913-.059Indication for endoscopyAbdominal pain.018^a^.0001.033.857^b^.016.181.857Vomiting.018^a^.0001.033.857^b^−.016−.181.857Laboratory dataAnemia.178^a^.0323.124.080^b^.0491.768.080Endoscopy findingNodules.356^a^.12713.945.000^b^.3933.734.000Erosions.059^a^.003.330.567^b^.086.5740.567Ulcers.074^a^.005.528.469^b^−.214-−.727-0.469Updated Sydney classificationChronicity.069^a^.005.449.504^a^−.043-−.670-.504Activity.304^a^.0939.801.002^a^−.290-−3.131-.002Atrophy.133^a^.0181.729.192^a^−.469-−1.315-.192Intestinal metaplasia.133^a^.0181.729.192^a^−.469-−1.315-.192[^4]

Discussion {#S0004}
==========

This is the first histology-based study about *H. pylori* prevalence and impact on Jordanian children. The prevalence rate was 54% among symptomatic children, and it compares to the rates in the literature from other Arab countries.[@CIT0021]--[@CIT0024] [Table 7](#T0007){ref-type="table"} summarizes these histology-based studies. Jordan's high prevalence rate is similar to those of Egypt and Saudi Arabia and almost double those of Oman and Kuwait.Table 7Histology-Based Prevalence of *H. pylori* in Arab World CountriesyearAuthorCountry*H. pylori* PrevalenceNo. of ChildrenStatus of Cohort1993Radhakrishnan^21^Kuwait31%60Symptomatic + healthy2005El-Mouzan^22^Saudi Arabia65%175Symptomatic2013El-Mazary^24^Egypt65%70Symptomatic2014Al-sinani^23^Oman25%112Symptomatic2015Shatnawi^30^Jordan82%163Symptomatic2019Khdair AhmadJordan54%98Symptomatic

In comparison to Jordanian adult prevalence rate of 82%, the HBP of *H. pylori* in Jordanian children is not as high.[@CIT0007] The majority of cases in children were above 10 years of age, with a low prevalence of *H. pylori* among children less than 5 years of age ([Table 2](#T0002){ref-type="table"}). This supports the data about acquisition of *H. pylori* infection in developing countries during childhood, and higher infection rates in adults.[@CIT0001],[@CIT0023] The high prevalence rate of *H. pylori* infection in Jordanian children, along with the high rate of *H. pylori* related gastric cancer in adult Jordanians,[@CIT0028] makes *H. pylori* eradication an important childhood issue. *H. pylori* infection is related to the socioeconomic status, sanitation level, living standards and the overall health level in the country.[@CIT0031] This is reflected by the ongoing decline in *H. pylori* and gastric cancer prevalence rates in the developed countries.[@CIT0032],[@CIT0033]

It is likely, though, the prevalence rate of *H. pylori* in Jordanian children could be higher than what is revealed by our study. This could be attributed to several culprits. The majority of children who did not have *H. pylori* in this study (70%) were on medications that can decrease the detection rate of *H. pylori*, like proton pump inhibitors (PPI). Others might have been on antibiotics week(s) before endoscopy. Further, no special stains, like Giemsa, were done to look for *H. pylori*, and histology was the only criterion used to confirm *H. pylori* presence. Other tests, like rapid urease test, serology, or tissue culture, were not implemented at the time of endoscopy.

The HBP rate in our study was lower than that conducted by Shatnawi et al in Jordanian children.[@CIT0030] This can be explained in part by the factors mentioned in the preceding paragraph. In addition, Shatnawi et al studied only dyspeptic children who lived in northern Jordan, where as our study looked at dyspeptic and other children, who underwent upper endoscopy from central Jordan. It is possible that the geographical factor contributes to HBP in Jordanian children. Further studies are needed to answer this question.

Despite the known shortcomings of serology testing, the prevalence of *H. pylori* in this histology -based study is close to the prevalence rate found by a prior serology-based study from Jordan.[@CIT0029] Using enzyme-linked immunosorbent assay (ELISA) for detection of serum IgG and IgA antibodies against *H. pylori* in 200 children, Bani-Hani et al reported a prevalence of *H. pylori* in healthy schoolchildren to be 55.5%. Although practice guidelines from the European and North American Society for pediatric gastroenterology, hepatology, and nutrition (ESPGHAN and NASPGHAN) advice against using serology testing for initial diagnosis of *H. pylori* infection in a clinical setting,[@CIT0005],[@CIT0009] we find in this study that there is a good correlation between our histology-based study and the prior serology-based study. The ESPGHAN/NASPGHAN recommendation is based on the low performance of serology testing in most European and North America countries, which is due to the low disease prevalence there.[@CIT0005],[@CIT0009] Known limitations for serology testing include its inability to differentiate ongoing from old infection and the lag of positive testing behind the clinical condition.[@CIT0008]

The majority of *H. pylori*-infected children in our study lived in central Jordan. This includes the districts of Amman (the capital of Jordan); Balqa, Zarqa; and Madaba. Few children lived in northern and southern Jordan. We believe this is due to the referral bias to our institution, which captures the majority of its patients from central Jordan. More studies at the national level are needed to verify the accurate epidemiology and distribution of *H. pylori* infection in Jordanian children. Although more boys than girls had *H. pylori* infection in this study (55% vs 45%), this was not statistically significant. Zamani et al's meta-analysis showed no gender difference in worldwide *H. pylori* prevalence,[@CIT0001] whereas Ibrahim et al recently in his meta-analysis showed a slight male predominance.[@CIT0034] More studies are needed to clarify any gender differences.

Although abdominal pain was the most common indication for endoscopy, it was not statistically different between children who had *H. pylori* infection and those that did not (p-value 0.2). This is likely due to the low prevalence of stomach ulcers in our study ([Table 4](#T0004){ref-type="table"}). The NASPGHAN/ESPGHAN guidelines indicate that *H. pylori* causes abdominal pain in children only when ulcers are present.[@CIT0005],[@CIT0009] This is also supported by the finding that the prevalence rate of *H. pylori* in this study of symptomatic children was close to its prevalence in the study of healthy schoolchildren in Jordan, with a rate of 54% and 55.5%, respectively.[@CIT0029]

Our study did not find a difference in the prevalence of anemia in the presence or absence of *H. pylori* infection. This might be due to small sample size and low prevalence of anemia in the whole cohort (13%). Due to the retrospective nature of this study and absent laboratory data, no analysis could have been performed regarding the type of anemia these children had, or to do the correlation between iron stores before and after treatment. Prospective studies can help in finding the answer to this important question.[@CIT0018],[@CIT0019]

Our study suffers from a few limitations. The retrospective nature of the study prohibited the evaluation of specific diagnostic methods like Giemsa staining, rapid urease test or tissue culture. It did not allow stopping PPI or antibiotics around the time of endoscopy, and made it difficult to assess the success of *H. pylori* identification, eradication, or effect on patients' symptoms or investigations. The study took JUH as the only site for the study, which resulted in the majority of the study population coming from central Jordan. More studies at the country level will provide a better understanding of the disease demography. Moreover, this study was not a mass screening study for all children in Jordan, but rather for the symptomatic ones who were referred to JUH. The result of our study should be interpreted in this context. Prospective screening studies at the country level looking for eradication rates of *H. pylori*, treatment regimen, and antibiotic sensitivity are needed.

Antibiotics use was not looked at in this study. Antibiotics in Jordan are given sometimes without a prescription in the private sector, and their use or its absence was not recorded routinely in all medical charts. Due to the retrospective nature of the study, it was difficult to track those who had antibiotics from those who did not. Future prospective studies should address this important issue.

Conclusion {#S0005}
==========

In conclusion, *H. pylori* infection among Jordanian children is common, with a prevalence rate reaching, at least, 54% in symptomatic children from central Jordan. Its prevalence tends to increase with age. Nodularity of the stomach is the most common positive endoscopic finding of its presence. Stomach ulcers were rare in this cohort. Moderate to severe active gastritis are associated with *Helicobacter pylori* in Jordanian children. The presence of *Helicobacter pylori* did not affect anemia status in this cohort of Jordanian children. Prospective studies at the country level are needed.
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[^1]: **Notes:** ^a^Northern Jordan: includes the districts of Irbid, Ajloun, Jerash, and Mafraq. ^b^Central Jordan includes the districts of Amman (the capital), Balqa, Zarqa, and Madaba. ^c^South Jordan includes the districts of: Ma'an, Kerak, Tafilah, and Aqaba.

[^2]: **Notes:** ^a^Northern Jordan: includes the districts of Irbid, Ajloun, Jerash, and Mafraq. ^b^Central Jordan includes the districts of Amman (the capital), Balqa, Zarqa, and Madaba. ^c^South Jordan includes the districts of Ma'an, Kerak, Tafilah, and Aqaba.

[^3]: **Notes:** ^a^Some patients had more than one indication for endoscopy. ^b^Refers in this table to the number of indications for endoscopy in this group (symptom or sign). ^c^Between H. pylori positive and H. pylori negative groups.

[^4]: **Note:** ^a^Dependent Variable: *H. pylori*.
